Home/Filings/4/0001209191-16-118169
4//SEC Filing

EnteroMedics Inc 4

Accession 0001209191-16-118169

CIK 0001371217operating

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:14 PM ET

Size

7.4 KB

Accession

0001209191-16-118169

Insider Transaction Report

Form 4
Period: 2016-05-04
Transactions
  • Award

    Director Option (Right to Buy)

    2016-05-04+3,0003,000 total
    Exercise: $0.75From: 2016-05-04Exp: 2026-05-04Common Stock (3,000 underlying)
Holdings
  • Director Option (Right to Buy)

    Exercise: $4.65Exp: 2025-07-31Common Stock (1,666 underlying)
    1,666
Footnotes (3)
  • [F1]On January 6, 2016, EnteroMedics Inc. effected a 1-for-15 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
  • [F2]25% of the shares subject to the option are exercisable immediately. The remaining 75% of the shares subject to the option shall vest in a series of thirty-six (36) successive equal monthly installments upon completion of each month beginning on August 31, 2015 and ending on July 31, 2018.
  • [F3]Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.

Issuer

EnteroMedics Inc

CIK 0001371217

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001371217

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:14 PM ET
Size
7.4 KB